Amundi Biomarin Pharmaceutical Inc Transaction History

Amundi

$264 Billion
Q3 2024

A detailed history of Amundi transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Amundi holds 310,991 shares of BMRN stock, worth $20 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

310,991

Previous 346,997 10.38%

Holding current value

$20 Million

Previous $28.6 Million 23.48%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $2.49 Million - $3.38 Million	-36,006 Reduced 10.38%	310,991 $21.9 Million
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $7.23 Million - $8.96 Million	-97,123 Reduced 21.87%	346,997 $28.6 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $5.78 Million - $6.82 Million	68,910 Added 18.37%	444,120 $38.8 Million
Q4 2023 Feb 14, 2024	SELL	$76.22 - $98.51 $30.3 Million - $39.2 Million	-397,780 Reduced 51.46%	375,210 $36.2 Million
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $29.1 Million - $32.3 Million	341,737 Added 79.24%	772,990 $68.4 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $63.8 Million - $73.8 Million	-736,068 Reduced 63.06%	431,253 $37.4 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $44.4 Million - $59.4 Million	-506,372 Reduced 30.25%	1,167,321 $114 Million
Q4 2022 Feb 14, 2023	SELL	$80.93 - $108.63 $5.72 Million - $7.68 Million	-70,739 Reduced 4.06%	1,673,693 $173 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $119 Million - $140 Million	1,448,878 Added 490.22%	1,744,432 $156 Million
Q2 2022 Aug 15, 2022	BUY	$71.48 - $86.85 $2.43 Million - $2.96 Million	34,039 Added 13.02%	295,554 $25.6 Million
Q1 2022 May 16, 2022	BUY	$74.28 - $92.69 $8.29 Million - $10.3 Million	111,623 Added 74.47%	261,515 $21.8 Million
Q4 2021 Feb 14, 2022	BUY	$71.72 - $91.47 $285,732 - $364,416	3,984 Added 2.73%	149,892 $13.2 Million
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $593,150 - $678,033	7,933 Added 5.75%	145,908 $11.3 Million
Q2 2021 Aug 16, 2021	BUY	$75.51 - $84.79 $10.4 Million - $11.7 Million	137,975 New	137,975 $11.5 Million

Others Institutions Holding BMRN

# of Institutions

636

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.9B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account